Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Nat Commun. 2021 May 13;12(1):2958. doi: 10.1038/s41467-021-23515-z.

Natalie N Kinloch^#^{1

2}, Yanqin Ren^#³, Winiffer D Conce Alberto³, Winnie Dong², Pragya Khadka³, Szu Han Huang³, Talia M Mota³, Andrew Wilson⁴, Aniqa Shahid^{1

2}, Don Kirkby², Marianne Harris^{2

5}, Colin Kovacs⁶, Erika Benko⁶, Mario A Ostrowski⁷, Perla M Del Rio Estrada⁸, Avery Wimpelberg⁹, Christopher Cannon⁹, W David Hardy⁹, Lynsay MacLaren⁹, Harris Goldstein¹⁰, Chanson J Brumme^{2

5}, Guinevere Q Lee³, Rebecca M Lynch⁴, Zabrina L Brumme^{11

12}, R Brad Jones^{13

14}

¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA.
⁵ Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁶ Maple Leaf Medical Clinic, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
⁹ Whitman Walker Health, Washington, DC, USA.
¹⁰ Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
¹¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada. zbrumme@sfu.ca.
¹² British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada. zbrumme@sfu.ca.
¹³ Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. rbjones@med.cornell.edu.
¹⁴ Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, USA. rbjones@med.cornell.edu.

^# Contributed equally.

No abstract available

Publication types